Skip to main content

Option Care Health Value Stock - Dividend - Research Selection

Bioscrip

ISIN: US68404L2016 , WKN: A2PZEY

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

BioScrip, Inc. provides infusion solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company offers its services at patient\'s homes, outpatient clinics, nursing facilities, physician\'s offices, and ambulatory infusion centers. It markets and sells its products and services through sales and marketing representatives, and payor relationships. The company was founded in 1993 and is based in Denver, Colorado.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call

2026-07-09
BANNOCKBURN, Ill., July 09, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2026 on Wednesday, July 29, 2026 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsPa

Why Option Care Health’s (OPCH) Alternate-Site Infusion Model Fits the Site-of-Care Shift

2026-07-07
Option Care Health, Inc. (NASDAQ:OPCH) is one of the best medical care facilities stocks to buy according to analysts. Analysts’ average target implies roughly 30.5% upside, placing the company seventh in this screen. The latest relevant update came on June 1, when Option Care Health said it had been ranked No. 15 on TIME’s World’s […]

Option Care Health: Mildly Interesting After Pullback

2026-07-05
Option Care Health stock is down 40% on the Stelara patent loss and insurance shifts. Click for more on OPCH stock prospects.

1 Stock Under $50 to Consider Right Now and 2 We Find Risky

2026-06-30
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.

Is Option Care Health, Inc. (OPCH) A Good Stock To Buy Now?

2026-06-22
Is OPCH a good stock to buy? We came across a bullish thesis on Option Care Health, Inc. on r/ValueInvesting by Unusual_Reveal_8569. In this article, we will summarize the bulls’ thesis on OPCH. Option Care Health, Inc.’s share was trading at $21.99 as of June 18th. OPCH’s trailing and forward P/E were 17.16 and 12.35 respectively according […]

Option Care Health Inc (NASDAQ:OPCH) Screens as a Strong Decent Value Pick with a P/E of 12.57

2026-06-17
Option Care Health (OPCH) offers decent value with a low P/E of 12.57, strong profitability, and solid growth, avoiding the value trap while trading at a discount to peers.

Should Goldman’s Neutral Stance Amid Slower Growth Shift How OPCH Investors View Its Home-Infusion Moat?

2026-06-13
Earlier in June 2026, Goldman Sachs initiated coverage on Option Care Health with a Neutral rating, highlighting long-term specialty infusion demand alongside near-term earnings uncertainty tied to therapy-specific disruptions in its chronic portfolio. This new coverage arrives after weak first-quarter results, reduced full-year revenue guidance, and a recent downgrade from Bank of America, sharpening investor focus on how slowing growth, tougher insurance approvals, and rising competition...

Option Care Health (OPCH) Stock Trades Up, Here Is Why

2026-06-09
Shares of alternate site health provider Option Care Health (NASDAQ:OPCH) jumped 3.7% in the morning session after Goldman Sachs initiated coverage on the stock with a Neutral rating and a $22 price target.

Billionaire Stanley Druckenmiller’s Long-Term Healthcare Stock Pick: Option Care Health (OPCH)

2026-06-08
We just covered the 10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller. Option Care Health (NASDAQ:OPCH) ranks #6 (see 5 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller). Druckenmiller’s Stake: $50,301,000 Option Care Health (NASDAQ:OPCH) provides home and outpatient infusion therapy services. It delivers medications like antibiotics and immune therapies […]

Goldman Sachs Initiates Coverage On Option Care Health with Neutral Rating, Announces Price Target of $22

2026-06-08
Goldman Sachs analyst Scott Fidel initiates coverage on Option Care Health (NASDAQ:OPCH) with a Neutral rating and announces Price Target of $22.